Back

microRNA-21 as a prognostic biomarker of sacubitril/valsartan treatment response in heart failure with reduced ejection fraction

27 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic Heart Failure – Treatment Pharmacotherapy HFA Premium Access Heart Failure 2019

About the speaker

Photo
Associate Professor Maria Marketou

University Hospital of Heraklion, Heraklion (Greece)

56 More presentations in this session

Presentation thumbnail
Doctor L. Borg (Msida, MT)
Abstract
Presentation thumbnail
Mr F. Cortes (Sevilla, ES)
Abstract
Presentation thumbnail
Professor B. Kanazirev (Varna, BG)
Abstract Slides
Presentation thumbnail
Associate Professor C. Hsu (Taipei, TW)
Abstract Slides
Presentation thumbnail
Doctor C. Hsieh (Taipei, TW)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2019

27 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Sacubitril/Valsartan efficacy on functional, laboratory, echocardiographic parameters: a real-world study
29 June 2021
thumbnail
Congress Presentation
MicroRNA assessment in secondary mitral regurgitation - evidence for remodelling mechanisms at a cellular level
1 July 2021
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Session
Heart failure and reduced ejection fraction: the bread and butter of cardiovascular imaging
13 December 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources